The new features, including connectors to third-party data sources, are aimed at making the AI assistant more useful for ...

With one click, developers can implement a Jira issue, whether a story, bug, task, or subtask, and the implementation will generate code from requirements in that issue, Tabnine said. Afterward, ...

Uncover the hidden pitfalls of Excel regression and learn why Python is the key to unlocking clean, efficient data analysis.

In this tutorial, you'll learn how to generate scannable barcodes in Excel in two simple steps. You will also learn how to create random barcodes. A barcode is a machine-readable representation of ...

You can now ask the Gemini app to directly generate “downloadable and ready-to-share files.” Google wants you to “quickly move from a brainstorm to a complete ...

Google may have just released a game-changer feature for Gemini users who like to export their AI sessions to documents. Instead of having to copy and paste, reformat, or deal with external apps not ...

Google has updated Gemini to generate and package downloadable files like PDFs, Word, and Excel directly in the chat. This new feature, available globally, aims to eliminate the need for manual ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...